Ameriprise
THRN

Ameriprise’s Thorne Healthtech, Inc. Common Stock THRN Stock Holding History

Ameriprise’s Portfolio THRN Stock Details THRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-31,368
Closed -$114K – 4056
2022
Q4 		$114K Sell
31,368
-103,355
-77% -$458K ﹤0.01% 3797
2022
Q3 		$637K Sell
134,723
-1,143
-0.8% -$5.75K ﹤0.01% 3301
2022
Q2 		$658K Buy
135,866
+10,297
+8% +$62.6K ﹤0.01% 3296
2022
Q1 		$799K Buy
125,569
+928
+0.7% +$5K ﹤0.01% 3302
2021
Q4 		$774K Buy
124,641
+31,471
+34% +$246K ﹤0.01% 3368
2021
Q3 		$806K Buy
+93,170
New +$760K ﹤0.01% 3249

Other funds holding THRN

EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
MA
MYDA Advisors Woodmere, New York $608M AUM 77.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ameriprise's THRN Position: Q1 2023 in Review

Ameriprise sold out of Thorne Healthtech, Inc. Common Stock (THRN) in Q1 2023, closing a stake of 31,368 shares — an estimated $114K sold.

Ameriprise first reported a position in THRN in Q3 2021 and held it in 6 quarters. The position peaked at $806K in Q3 2021. 44 funds tracked by Wall St. Rank hold THRN as of Q1 2023.

  • Ameriprise reported no remaining Thorne Healthtech, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Ameriprise sold 31,368 Thorne Healthtech, Inc. Common Stock shares in Q1 2023, an estimated $114K.
  • Ameriprise first reported a position in Thorne Healthtech, Inc. Common Stock in Q3 2021 and held it in 6 quarters.
  • Ameriprise's Thorne Healthtech, Inc. Common Stock position peaked at $806K in Q3 2021.
  • 44 funds tracked by Wall St. Rank held Thorne Healthtech, Inc. Common Stock as of Q1 2023.

Based on Ameriprise's 13F filing for Q1 2023, filed 15 May 2023.